https://www.selleckchem.com/pr....oducts/pf-3644022.ht
ng the system over time, they improve glycemic control. German Clinical Trials Register no. DRKS00015439; https//www.drks.de/drks_web/navigate.....do?navigationId=tria German Clinical Trials Register no. DRKS00015439; https//www.drks.de/drks_web/navigate.....do?navigationId=triaColony Stimulating Factor 1 Receptor (CSF1R) is a potential target for anti-epileptic drugs. However, inhibition of CSF1R is not well tolerated by patients, thereby prompting the need for alternative ta
Curtir
Comentario
Compartilhar
